Michael Spenceley (US)
Leader, Learning & Content Standards at Johnson & Johnson
Previously a decade with PwC as forensic analyst, business development manager and finally as communications director
Based in the Tampa Bay Area
Meet Michael at
CMS Kickoff 26
Dates: January 13 - 14
Venue: The James Museum, St. Pete, FL
Mike gave a great talk at the CMS Kickoff 23 held at the Don Cesar in St. Pete Beach
About Michael Spenceley
Michael Spenceley is Leader, Learning & Content Standards (Innovative Medicine) at Johnson & Johnson Innovative Medicine. A visionary, strategic, and conceptual thinker, he generates new ideas and initiates change, bringing clarity and direction to complex challenges.
In his current role, Michael leads and shapes the creation of end-to-end learning and content standards across Johnson & Johnson Innovative Medicine, including frameworks for design, development, modality, and facilitation. He partners closely with learning content creators to drive consistency and reusability across therapeutic areas, and develops governance that ensures quality and alignment, helping to deliver a world-class learning experience for employees.
Michael is recognised for working effectively with cross-functional teams to produce actionable solutions that support innovation, business development, and process improvement. He also has a proven track record of leading through disruption, fostering an agile, startup culture within large organisations, and building momentum that translates strategy into measurable outcomes.
About Johnson & Johnson
Johnson & Johnson (J&J) is a global healthcare company founded in 1886 and headquartered in New Brunswick, New Jersey (USA). It operates worldwide and is listed on the New York Stock Exchange (NYSE: JNJ), with a long history of developing healthcare products across multiple domains.
Today, J&J is organised into two main business segments: Innovative Medicine (pharmaceuticals) and MedTech (medical technology and devices). Through these areas, the company focuses on bringing new therapies and technologies to patients, working across research, development, manufacturing, and commercialisation at global scale.
A key recent milestone was the separation of its former Consumer Health business into Kenvue, which became fully independent in August 2023. This shift sharpened J&J’s focus on Innovative Medicine and MedTech as its core operating structure.
Blog posts with Michael
Past Boye conference appearances
CMS Kickoff 25
Presentation: How Generative AI is making content king again
Slides: Download (PowerPoint)
CMS Kickoff 23
Presentation: How to build a high performing content team
Slides: Download (PowerPoint)